Neutral impactStocks
Indegene Stock Gets Fresh Buy Call; Motilal Oswal Turns Bullish On Pharma Outsourcing Tailwinds — Check Target Price
NDTV Profit 2 hrs ago·25 Sept 2026, 5:12 am
Domestic brokerage firm Motilal Oswal has upgraded its rating on Indegene to 'Buy' from Neutral
Affected stocks
Neutral1 stock
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Indegene (INDGN).
- Category: Stocks.
Why it matters
A routine update for Indegene. Use the price and stock snapshot to gauge how the market is responding.
